FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Cherill

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
Richard G B Langley; Lawrence F Eichenfield; Anne W Lucky; Mark Boguniewicz; Nathalie Barbier; Robert Cherill
Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis.
Klaus Wolff; C Fleming; Jon M Hanifin; Kim A Papp; Sakari Reitamo; M Rustin; N Shear; W Silny; N Korman; I Marks; Robert Cherill; S Emady-Azar; Carle Paul
Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial.
A B Gottlieb; Christopher E M Griffiths; Vincent C Ho; Morad Lahfa; U Mrowietz; Dédée F Murrell; Jean-Paul Ortonne; G Todd; Robert Cherill; I Marks; S Emady-Azar; Carle Paul
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Cherill (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Richard G B Langley; Lawrence F Eichenfield; Anne W Lucky; Mark Boguniewicz; Nathalie Barbier; Robert Cherill
Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis.
Pediatric dermatology 2008;25(3):301-7.
2005: Klaus Wolff; C Fleming; Jon M Hanifin; Kim A Papp; Sakari Reitamo; M Rustin; N Shear; W Silny; N Korman; I Marks; Robert Cherill; S Emady-Azar; Carle Paul
Efficacy and tolerability of three different doses of oral pimecrolimus in the treatment of moderate to severe atopic dermatitis: a randomized controlled trial.
The British journal of dermatology 2005;152(6):1296-303.
2005: A B Gottlieb; Christopher E M Griffiths; Vincent C Ho; Morad Lahfa; U Mrowietz; Dédée F Murrell; Jean-Paul Ortonne; G Todd; Robert Cherill; I Marks; S Emady-Azar; Carle Paul
Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.
The British journal of dermatology 2005;152(6):1219-27.
2004: Donald V Belsito; Joseph F Fowler; James G Marks; David M Pariser; Jon M Hanifin; Ida Alzira Gomes Duarte; Mario C Pires; Ponciano D Cruz; Richard G B Langley; Premal Patel; Christopher Bush; Mark Thurston; Michael Graeber; Robert Cherill
Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis.
Cutis; cutaneous medicine for the practitioner 2004;73(1):31-8.
2004: Nathalie Barbier; Carle Paul; T Luger; R Allen; Yves de Prost; Kim A Papp; L F Eichenfield; Robert Cherill; Jon M Hanifin
Validation of the Eczema Area and Severity Index for atopic dermatitis in a cohort of 1550 patients from the pimecrolimus cream 1% randomized controlled clinical trials programme.
The British journal of dermatology 2004;150(1):96-102.
2003: Lawrence F Eichenfield; Anne W Lucky; Mark Boguniewicz; Richard G B Langley; Robert Cherill; Katharine Marshall
1% pimecrolimus cream for atopic dermatitis.
Archives of dermatology 2003;139(10):1369-70; author reply 1370-1.
2003: Vincent C Ho; Aditya Gupta; Roland Kaufmann; Gail Todd; Francisco Vanaclocha; Roberto Takaoka; Regina Fölster-Holst; Paul Potter; Katharine Marshall; Mark Thurston; Christopher Bush; Robert Cherill
Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants.
The Journal of pediatrics 2003;142(2):155-62.
2002: Ulrich Wahn; Jan D Bos; M J D Goodfield; Ruggero Caputo; Kim A Papp; Ahmed Manjra; Attila Dobozy; Carle Paul; Stephen Molloy; Thomas Hultsch; Michael Graeber; Robert Cherill; Yves de Prost
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Pediatrics 2002;110(1 Pt 1):e2.
2002: Lawrence F Eichenfield; Anne W Lucky; Mark Boguniewicz; Richard G B Langley; Robert Cherill; Katharine Marshall; Christopher Bush; Michael Graeber
Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.
Journal of the American Academy of Dermatology 2002;46(4):495-504.
2001: Jon M Hanifin; Mark Thurston; M Omoto; Robert Cherill; Susan J Tofte; M Graeber
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group.
Experimental dermatology 2001;10(1):11-8.